ORGO
Overvalued by 180.8% based on the discounted cash flow analysis.
Market cap | $300.88 Million |
---|---|
Enterprise Value | $279.82 Million |
Dividend Yield | $0.0 (0.0%) |
Earnings per Share | $0.04 |
Beta | 1.85 |
Outstanding Shares | 131,963,176 |
Avg 30 Day Volume | 1,281,084 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 60.84 |
---|---|
PEG | -207.88 |
Price to Sales | 0.95 |
Price to Book Ratio | 1.43 |
Enterprise Value to Revenue | 0.64 |
Enterprise Value to EBIT | 22.08 |
Enterprise Value to Net Income | 48 |
Total Debt to Enterprise | 0.24 |
Debt to Equity | 0.24 |
No data
No data